Case report on Brucella periprosthetic joint infection after knee replacement
This publication is a case report describing two patients with Brucella-induced periprosthetic joint infection after total knee arthroplasty. The report's scope is to detail the diagnosis and management of this rare infection. For one chronic case, treatment involved anti-infective therapy with ceftriaxone sodium combined with doxycycline. For one acute case, treatment involved debridement and implant retention surgery followed by anti-infective therapy with ceftriaxone sodium combined with rifampicin.
The authors report that over a follow-up of at least 12 months, inflammatory markers returned to normal, the Brucella agglutination test titer decreased to the normal range, and knee joint range of motion was restored. No pooled effect sizes, p-values, or confidence intervals are provided, as this is a case report.
The authors note no specific limitations for this report. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. The practice relevance is that this report can serve as a reference for the diagnosis and treatment of such rare infections in livestock-farming regions. The evidence is from a single case report and should be interpreted with caution.